Nureca Limited

₹304.30As of Sun 8 Nov 2026, 12:00 UTC
NSE:NURECAHealthcare
Country India
PE (Fwd) •••
TSR 6Y CAGR (13.08%)
Div yield —
ROE 2.46%
Medical Devices
Beta (5Y) 0.64
PE TTM 61.61
TSR TTM 16.37%
Mkt cap ₹2.904B
ROIC 1.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹382
25.52%
457.26%
Hold 1|6|1|6|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
4.09
4.36
4.18
4.44
37.04%
31.62%
13.76%
18.07%
Revenue₹M
343.1
351.5
368.4
387.7
(1.37%)
3.19%
10.10%
13.50%
Peers (US$30.48M)
Cap (US$)
PE
170.5M
57.51x
55.95M
—
30.85M
32.05x
Capital
TTM
5Y
10Y
Leveragex
0.505
0.745
0.620
EBIT/Intx
0.133
0.217
0.208
Own earn%
21.11
71.98
87.37
Sh yield%
35.49
29.92
29.07
Owners
Insiders/Inst%
14.42
36.23
Short interest%
0.86
SBC / revenue%
0.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
2–7
$1 testx
—
Incr. ROIC%
6